Mayer Brown JSM advises Fosun Pharmaceutical on private placement in Nature’s Sunshine Products
7 July 2014
Mayer Brown JSM has advised Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma") on its subscription of shares in Nature's Sunshine Products, Inc. ("NSP"), a NASDAQ-listed US manufacturer of natural health supplements, for a consideration of approximately US$46.3 million pursuant to a private placement
The firm is also advising Fosun Industrial (HK) Co., Ltd. ("Fosun Industrial"), a wholly-owned subsidiary of Fosun Pharma, on the establishment of a China joint venture with NSP, to market and distribute Nature's Sunshine and Synergy products in China. The strategic partnership highlights Fosun Pharma's commitment to investing in companies that deliver value in the rapidly growing business segments in China and internationally. The joint venture is the first-of-its-kind direct selling company between a Chinese and a US company to operate in China, giving the new venture a competitive edge in the marketplace. The team consists partners Betty Tam (Shanghai), Reb Wheeler, John Berkery (New York) and Martin Robertson (Hong Kong), and they were assisted by senior associate Gavin Guo
(Shanghai), associate Mandee Lee (New York) and associate Chandy Ye (Hong Kong).